TP53 and Parkinson disease: In this report, the authors showed that nuclear acetylated p53 is upregulated in consistent with the evidence that p53 is a major deacetylation substrate of SIRT2 [109], and decreased cytoplasmic p53 promotes autophagy in the Parkinson’s disease model [64].